{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:25:42Z","timestamp":1790267142268,"version":"4.1.0"},"reference-count":99,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pubertal children with significant growth retardation represent a considerable therapeutic challenge. In growth hormone (GH) deficiency, and in those without identifiable pathologies (idiopathic short stature), the impact of using GH is significantly hindered by the relentless tempo of bone age acceleration caused by sex steroids, limiting time available for growth. Estrogen principally modulates epiphyseal fusion in females and males. GH production rates and growth velocity more than double during puberty, and high-dose GH use has shown dose-dependent increases in linear growth, but also can raise insulin-like growth factor I concentrations supraphysiologically, and increase treatment costs. Gonadotropin-releasing hormone analogs (GnRHas) suppress physiologic puberty, and when used in combination with GH can meaningfully increase height potential in males and females while rendering adolescents temporarily hypogonadal at a critical time in development. Aromatase inhibitors (AIs) block androgen to estrogen conversion, slowing down growth plate fusion, while allowing normal virilization in males and stimulating longitudinal bone growth via androgen receptor effects on the growth plate. Here, we review the physiology of pubertal growth, estrogen and androgen action on the epiphyses, and the therapeutic impact of GH, alone and in combination with GnRHa and with AIs. The pharmacology of potent oral AIs, and pivotal work on their efficacy and safety in children is also reviewed. Time-limited use of AIs is a viable alternative to promote growth in pubertal males, particularly combined with GH. Use of targeted growth-promoting therapies in adolescence must consider the impact of sex steroids on growth plate fusion, and treatment should be individualized.<\/jats:p>","DOI":"10.1210\/endrev\/bnac014","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T20:03:04Z","timestamp":1654027384000},"page":"1-13","source":"Crossref","is-referenced-by-count":71,"title":["Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review"],"prefix":"10.1210","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-3852","authenticated-orcid":false,"given":"Nelly","family":"Mauras","sequence":"first","affiliation":[{"name":"Nemours Children\u2019s Health Jacksonville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ross","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health Wilmington , DE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2287-0181","authenticated-orcid":false,"given":"Veronica","family":"Mericq","sequence":"additional","affiliation":[{"name":"University of Chile , Santiago , Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2213-8587(15)00418-0","article-title":"Pubertal development and regulation. Review","volume":"4","author":"Abreu","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2826.2008.01731.x","article-title":"Kisspeptin and GPR54: discovery of a novel pathway in reproduction","volume":"20","author":"Seminara","year":"2008","journal-title":"J Neuroendocrinol."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","article-title":"Central precocious puberty caused by mutations in the imprinted gene MKRN3","volume":"368","author":"Abreu","year":"2013","journal-title":"N Engl J Med."},{"issue":"4","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"EMBO Mol Med."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"110967","DOI":"10.1016\/j.mce.2020.110967","article-title":"Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects","volume":"518","author":"Fujimoto","year":"2020","journal-title":"Mol Cell Endocrinol."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1507\/endocrj.K10E-164","article-title":"Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias","volume":"57","author":"Yasoda","year":"2010","journal-title":"Endocr J."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa1813446","article-title":"C-type natriuretic peptide analogue therapy in children with achondroplasia","volume":"381","author":"Savarirayan","year":"2019","journal-title":"N Engl J Med."},{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-69-3-563","article-title":"Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys","volume":"69","author":"Martha","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/er.2003-0038","article-title":"Endocrine control of body composition in infancy, childhood, and puberty","volume":"26","author":"Veldhuis","year":"2005","journal-title":"Endocr Rev."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jcem-62-1-159","article-title":"The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males","volume":"62","author":"Link","year":"1986","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/jcem-64-3-596","article-title":"Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon","volume":"64","author":"Mauras","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2023040316441258000_","first-page":"513","article-title":"Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence","volume":"79","author":"Metzger","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/jc.2005-1693","article-title":"Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone","volume":"91","author":"Vottero","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000358195","article-title":"Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use","volume":"81","author":"Sas","year":"2014","journal-title":"Horm Res Paediatr."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/jc.2014-3631","article-title":"Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy","volume":"100","author":"Lawaetz","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:16:1:01","article-title":"Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats","volume":"16","author":"Phillip","year":"2001","journal-title":"Endocrine"},{"key":"2023040316441258000_","first-page":"157","article-title":"Endocrine regulation of the growth plate","volume":"64","author":"Nilsson","year":"2005","journal-title":"Horm Res."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med."},{"key":"2023040316441258000_","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00018-013-1317-1","article-title":"The role of estrogen receptor alpha in the regulation of bone and growth plate cartilage","volume":"70","author":"Borjesson","year":"2013","journal-title":"Cell Mol Life Sci."},{"issue":"8","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/en.2013-2175","article-title":"Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits","volume":"155","author":"Nilsson","year":"2014","journal-title":"Endocrinology"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med."},{"issue":"10","key":"2023040316441258000_","first-page":"3653","article-title":"High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12902-015-0080-8","article-title":"Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain","volume":"15","author":"Lundberg","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1210\/jc.2007-0204","article-title":"A randomized, controlled study","volume":"92","author":"Cohen","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-i treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-i deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2023040316441258000_","first-page":"569","article-title":"Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial","volume":"85","author":"Mericq","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2023040316441258000_","first-page":"2969","article-title":"A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation","volume":"86","author":"Kamp","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2009-1577","article-title":"Effectiveness of the combined recombinant human growth hormone and gonadotropin releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency","volume":"95","author":"Scalco","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/JPEM.2003.16.7.1005","article-title":"Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution","volume":"16","author":"Pucarelli","year":"2003","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"6","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000084097","article-title":"Gonadotropin-releasing hormone analogue treatment for precocious puberty","volume":"8","author":"Heger","year":"2005","journal-title":"Endocr Dev."},{"issue":"2","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/17446651.2019.1575726","article-title":"Update on central precocious puberty: from etiologies to outcomes","volume":"14","author":"Cantas-Orsdemir","year":"2019","journal-title":"Exp Rev Endocrinol Metab"},{"issue":"10","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2006-2272","article-title":"Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty","volume":"92","author":"van Gool","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/eje.0.151s047","article-title":"Bone development during GH and GnRH analog treatment","volume":"151","author":"Antoniazzi","year":"2004","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.6065\/apem.2016.21.3.155","article-title":"Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue","volume":"21","author":"Choi","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12955-021-01805-w","article-title":"The association between family impact and health-related quality of life of children with idiopathic central precocious puberty in Chongqing, China","volume":"19","author":"Yang","year":"2021","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1515\/jpem-2016-0425","article-title":"Assessment of stress levels in girls with central precocious puberty before and during long-acting gonadotropin-releasing hormone agonist treatment: a pilot study","volume":"30","author":"Menk","year":"2017","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"102617","DOI":"10.1016\/j.ajp.2021.102617","article-title":"Managing precocious puberty: a necessity for psychiatric evaluation","volume":"58","author":"Temelturk","year":"2021","journal-title":"Asian J Psychiatr"},{"issue":"3)","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03007995.2019.1699517","article-title":"A survey of care pathway and health-related quality of life impact for children with central precocious puberty","volume":"36","author":"Klein","year":"2020","journal-title":"Cur Med Res Opin"},{"issue":"2","key":"2023040316441258000_","first-page":"77","article-title":"Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment","volume":"64","author":"Visser-van Balen","year":"2005","journal-title":"Horm Res."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fpsyg.2016.01053","article-title":"Cognitive, emotional, and psychosocial functioning of girls treated with pharmacological puberty blockage for idiopathic central precocious puberty","volume":"7","author":"Wojniusz","year":"2016","journal-title":"Front Psychol."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000438895","article-title":"Treatment of peripheral precocious puberty","volume":"29","author":"Schoelwer","year":"2016","journal-title":"Endocr Dev."},{"issue":"9","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1651-2227.2001.tb01349.x","article-title":"Psychological assessments before and after treatment of early puberty in adopted children","volume":"90","author":"Mul","year":"2001","journal-title":"Acta Paediatr."},{"issue":"11","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1210\/jc.2018-01463","article-title":"Cognition, health-related quality of life, and psychosocial functioning after GH\/GnRHa treatment in young adults born SGA","volume":"103","author":"Goedegebuure","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2023040316441258000_","first-page":"1886","article-title":"Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity","volume":"83","author":"Mauras","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1359\/jbmr.1999.14.4.577","article-title":"Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study","volume":"14","author":"Mauras","year":"1999","journal-title":"J Bone Miner Res."},{"issue":"1-2","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, Aromatase Inhibitors, and Breast Cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"J Steroid Biochem Mol Biol."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.1996.531","article-title":"Influence of anastrozole (Arimidex\u00ae), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer","volume":"74","author":"Geisler","year":"1996","journal-title":"Br J Cancer."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole (Femara) and anastrozole (Arimidex) on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over-designed study","volume":"20","author":"Geisler","year":"2002","journal-title":"J Clin Oncol."},{"key":"2023040316441258000_","first-page":"2089","article-title":"In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/annonc\/mdq337","article-title":"The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum","volume":"22","author":"L\u00f8nning","year":"2011","journal-title":"Ann Oncol."},{"issue":"8","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2008-2527","article-title":"Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia","volume":"94","author":"Mauras","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1210\/jc.2003-031279","article-title":"Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males","volume":"88","author":"Mauras","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2023040316441258000_","first-page":"2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0140-6736(00)04895-9","article-title":"A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial","volume":"357","author":"Wickman","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00201","article-title":"Letrozole monotherapy in pre and early-pubertal boys does not increase adult height","volume":"10","author":"Varimo","year":"2019","journal-title":"Front Endocrinol."},{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","article-title":"Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter rial for one to three years","volume":"93","author":"Mauras","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2016-2891","article-title":"Randomized trial of aromatase inhibitors, growth hormone or combination in pubertal, idiopathic short stature boys","volume":"101","author":"Mauras","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1687-9856-2015-4","article-title":"randomized pilot trial of growth hormone with anastrozole versus growth hormone alone starting at the very end of puberty in adolescents with idiopathic short stature","volume":"2015","author":"Rothenbuhler","year":"2015","journal-title":"Int J Pediatr Endocrinol"},{"key":"2023040316441258000_","first-page":"1","article-title":"Height outcomes in children with GH deficiency","volume":"19","author":"Miller","year":"2020","journal-title":"Int J Ped Endocrinol"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000315482","article-title":"A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature","volume":"74","author":"Salehpour","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2017.07.047","article-title":"Effect of antiandrogen, aromatase inhibitor, and gonadotropin-releasing hormone analog on adult height in familial male precocious puberty","volume":"190","author":"Leschek","year":"2017","journal-title":"J Pediatr."},{"key":"2023040316441258000_","author":"Centers for Disease Control and Prevention"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1515\/jpem-2013-0470","article-title":"Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and\/or rapid pubertal progress: a retrospective chart review","volume":"27","author":"Shams","year":"2014","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"812196","DOI":"10.3389\/fendo.2021.812196","article-title":"Should skeletal maturation be manipulated for extra height gain?","volume":"12","author":"Wit","year":"2021","journal-title":"Front Endocrinol."},{"issue":"5","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1530\/EC-20-0090","article-title":"Adult height prediction by bone age determination in children with isolated growth hormone deficiency","volume":"9","author":"Reinehr","year":"2020","journal-title":"Endocr Connect"},{"key":"2023040316441258000_","first-page":"290","article-title":"Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature","volume":"71","author":"Hero","year":"2009","journal-title":"Horm Res."},{"issue":"7","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.56","article-title":"Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty","volume":"25","author":"Hero","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0034-1386753","article-title":"Incidental findings on magnetic resonance imaging of the spine in the asymptomatic pediatric population: a systematic review","volume":"5","author":"Ramadorai","year":"2014","journal-title":"Evid Based Spine Care J"},{"issue":"4","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00247-014-3210-y","article-title":"Canadian STOPP Consortium National Pediatric Bone Health Working Group. Common normal variants of pediatric vertebral development that mimic fractures: a pictorial review from a national longitudinal bone health study","volume":"45","author":"Jaremko","year":"2015","journal-title":"Pediatr Radiol."},{"issue":"14","key":"2023040316441258000_","first-page":"9","article-title":"Cognitive effects of aromatase inhibitor therapy in peripubertal boys","volume":"163","author":"Hero","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1477-7525-11-76","article-title":"Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument","volume":"11","author":"Bullinger","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"2023040316441258000_","article-title":"Quality of life in adolescent boys with idiopathic short stature: positive impact of growth hormone and aromatase inhibitors","volume":"1","author":"Bullinger","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1073\/pnas.90.23.11162","article-title":"Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene","volume":"90","author":"Lubahn","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"2023040316441258000_","first-page":"263","volume-title":"Developmental and Reproductive Toxicology: A Practical Approach","author":"Beck","year":"2006","edition":"2nd"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fertnstert.2005.02.012","article-title":"Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: comparison with normal controls","volume":"84","author":"Mauras","year":"2005","journal-title":"Fertil Steril"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.fertnstert.2016.11.021","article-title":"Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men","volume":"107","author":"Shoshany","year":"2017","journal-title":"Fertil Steril."},{"issue":"4s","key":"2023040316441258000_","article-title":"Outcomes of anastrozole in the treatment of subfertile males with body mass index &gt; kg\/m2","volume":"199","author":"Tejash Shah","year":"2018","journal-title":"J Urol"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.10.023","article-title":"Aromatase inhibitors for male infertility","volume":"90","author":"Schlegel","year":"2012","journal-title":"Fertil Steril."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2013.06.010","article-title":"Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor","volume":"100","author":"Mehta","year":"2013","journal-title":"Fer Steril."},{"issue":"2","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5935\/1518-0557.20160019","article-title":"Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials","volume":"20","author":"Ribeiro","year":"2016","journal-title":"JBRA Assisted Reproduction"},{"key":"2023040316441258000_","first-page":"119","article-title":"Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases","volume":"173","author":"Kyrou","year":"2014","journal-title":"Eur J Obst Gyn Rep Biol."},{"key":"2023040316441258000_"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.1.02226","article-title":"Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition","volume":"155","author":"Hero","year":"2006","journal-title":"Eur J of Endocrinol."},{"issue":"10","key":"2023040316441258000_","first-page":"999","article-title":"Bicalutamide plus anastrozole for the treatment of gonadotropin independent precocity in boys","volume":"23","author":"Reiter","year":"2010","journal-title":"J Ped Endo Metab"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/cen.14009","article-title":"Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: impact of anastrozole on bone mineral density and visceral adipose tissue","volume":"91","author":"Halper","year":"2019","journal-title":"Clin Endocrinol."},{"issue":"3","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000501746","article-title":"Aromatase inhibitor as treatment for severely advanced bone age in congenital adrenal hyperplasia: a case report","volume":"92","author":"Goedegebuure","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/EJE-07-0663","article-title":"Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism","volume":"158","author":"Loves","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2005-1923","article-title":"Review: aromatase inhibitors for ovulation induction","volume":"91","author":"Casper","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2013-1328","article-title":"The use of aromatase inhibitors for ovulation induction and superovulation","volume":"98","author":"Pavone","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1210\/jc.2007-2090","article-title":"The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome","volume":"93","author":"Mieszczak","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-16-0526","article-title":"Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome","volume":"175","author":"Estrada","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40618-015-0399-z","article-title":"Anastrozole plus leuprorelin in early maturing girls with compromised growth: the \u201cGAIL\u201d study","volume":"39","author":"Papadimitriou","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"2023040316441258000_","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children","volume":"133","author":"Committee on Drugs Policy Statement","year":"2014","journal-title":"Pediatrics"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnac014\/44082130\/bnac014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/1\/1\/49733114\/bnac014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/1\/1\/49733114\/bnac014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T13:21:55Z","timestamp":1700659315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/44\/1\/1\/6594238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,27]]},"published-print":{"date-parts":[[2023,1,12]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnac014","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,5,27]]}}}